Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

Interest in CBG (cannabigerol) has been growing in the past few years, due to its anti-inflammatory properties and other therapeutic benefits. Here we report the synthesis of three new CBG derivatives (HUM-223, HUM-233 and HUM-234) and show them to possess anti-inflammatory and analgesic properties....

Descripción completa

Detalles Bibliográficos
Autores principales: Kogan, Natalya M., Lavi, Yarden, Topping, Louise M., Williams, Richard. O., McCann, Fiona E., Yekhtin, Zhanna, Feldmann, Marc, Gallily, Ruth, Mechoulam, Raphael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467477/
https://www.ncbi.nlm.nih.gov/pubmed/34577072
http://dx.doi.org/10.3390/molecules26185601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467477/
https://www.ncbi.nlm.nih.gov/pubmed/34577072
http://dx.doi.org/10.3390/molecules26185601

Ejemplares similares